Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hartman

Showing results (331-340 of 459) with videos related to

Pageof 46
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 18, 2011
Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine seriesScott D Kuduk, Ronald K Chang, Christina N Di Marco, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2006
Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamidesZhijian Zhao, Julie A O'Brien, Wei Lemaire, et al.
Redox Biology|April 30, 2025
Ref-1 redox activity modulates canonical Wnt signaling in endothelial cellsGabriella D Hartman, Kamakshi Sishtla, Eyram K Kpenu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Quinolizidinone carboxylic acids as CNS penetrant, selective m1 allosteric muscarinic receptor modulatorsScott D Kuduk, Ronald K Chang, Christina N Di Marco, et al.
Biochemical Society Transactions|August 1, 1996
Farnesyltransferase inhibitors: a new class of cancer chemotherapeuticsK S Koblan, N E Kohl, C A Omer, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivativesJiabing Wang, Michael J Breslin, Paul J Coleman, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitorsZhijian Zhao, William H Leister, Ronald G Robinson, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulatorsScott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Benzimidazole CB2 agonists: design, synthesis and SARKausik K Nanda, Darrell A Henze, Kimberly Della Penna, et al.
Critical Care Medicine|June 5, 2024
Optic Nerve Sheath Diameter Point-of-Care Ultrasonography Quality Criteria Checklist: An International Consensus Statement on Optic Nerve Sheath Diameter Imaging and MeasurementMohammad I Hirzallah, Piergiorgio Lochner, Muhammad Ubaid Hafeez, et al.
Pageof 46

Showing results (331-340 of 459) with videos related to

Sort By:
Pageof 46
Bioorganic & Medicinal Chemistry Letters|February 18, 2011
Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine seriesScott D Kuduk, Ronald K Chang, Christina N Di Marco, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2006
Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamidesZhijian Zhao, Julie A O'Brien, Wei Lemaire, et al.
Redox Biology|April 30, 2025
Ref-1 redox activity modulates canonical Wnt signaling in endothelial cellsGabriella D Hartman, Kamakshi Sishtla, Eyram K Kpenu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Quinolizidinone carboxylic acids as CNS penetrant, selective m1 allosteric muscarinic receptor modulatorsScott D Kuduk, Ronald K Chang, Christina N Di Marco, et al.
Biochemical Society Transactions|August 1, 1996
Farnesyltransferase inhibitors: a new class of cancer chemotherapeuticsK S Koblan, N E Kohl, C A Omer, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivativesJiabing Wang, Michael J Breslin, Paul J Coleman, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitorsZhijian Zhao, William H Leister, Ronald G Robinson, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulatorsScott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Benzimidazole CB2 agonists: design, synthesis and SARKausik K Nanda, Darrell A Henze, Kimberly Della Penna, et al.
Critical Care Medicine|June 5, 2024
Optic Nerve Sheath Diameter Point-of-Care Ultrasonography Quality Criteria Checklist: An International Consensus Statement on Optic Nerve Sheath Diameter Imaging and MeasurementMohammad I Hirzallah, Piergiorgio Lochner, Muhammad Ubaid Hafeez, et al.
Pageof 46